Table 2.
The difference between AD tumor /AD RBM for treatment with 177 Lu and 90 Y
| Patient number | Ratio tumor/RBM dose | Percentage difference | |
|---|---|---|---|
| 177 Lu | 90 Y | ||
| 7 | 1.88 | 2.13 | 13% |
| 10 | 5.72 | 6.54 | 14% |
| 11 | 8.84 | 9.78 | 11% |
| 12 | 5.08 | 7.27 | 43% |
| 13 | 4.33 | 4.33 | 0% |
| 14 | 5.26 | 6.37 | 21% |
| 15 | 1.49 | 2.29 | 54% |
| 16 | 0.68 | 1.06 | 56% |
| 17 | 1.46 | 2.02 | 39% |
| 18 | 9.45 | 8.87 | −6% |
| 19 | 5.11 | 4.97 | −3% |
| 20 | 0.64 | 0.99 | 54% |
| 21 | 10.91 | 13.72 | 26% |
A positive difference represents a higher tumor-to-RBM dose ratio in 90Y, and the percentage is calculated compared to the 177Lu ratio. RBM = red bone marrow.